Dexcel Pharma Technologies Ltd. Insider Trades

Insider Trading History

Track insider trading activity for Dexcel Pharma Technologies Ltd.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $2.95B 102,849,443 shares
Last Trade
Nov 10, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20M 4,000,000 shares
$5.00
$28.70
Holding Value $2.84B 98,849,443 shares
Last Trade
Apr 25, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.6k 8,600 shares
$3.91
$28.70
Holding Value $2.84B 98,840,843 shares
Last Trade
Apr 22, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$121k 31,685 shares
$3.83
$28.70
Holding Value $7.13M 3,637,314 shares
Last Trade
Jun 03, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.93M 857,506 shares
$2.25
$1.96
Holding Value $8.81M 4,494,820 shares
Last Trade
Jun 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$157k 61,211 shares
$2.56
$1.96
Holding Value $0 0 shares
Last Trade
Mar 11, 2020 Sale
$6.65M 2,816,901 shares
$2.36
$1.96
Holding Value $40.8M 4,234,897 shares
Last Trade
Feb 04, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.46M 110,000 shares
$22.32
$9.63
Holding Value $41.8M 4,344,897 shares
Last Trade
Feb 03, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.89M 80,000 shares
$23.60
$9.63
Holding Value $42.6M 4,424,897 shares
Last Trade
Jan 31, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.9M 725,951 shares
$23.26
$9.63

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up